# To Investigate the Safety, Tolerability and Pharmacokinetics of AZD2516 After Multiple Dosing in Healthy Volunteers

> **NCT01148095** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 6 (actual)

## Conditions studied

- Part A Healthy Young Males and Non-fertile Female Volunteers Aged 20 to 45 Years.
- Part B Healthy Young Males and Non-fertile Female Volunteers Aged 20 to 45 and Elderly Volunteers Aged 60 to 80

## Interventions

- **DRUG:** AZD2516
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01148095
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2011-02-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01148095

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01148095, "To Investigate the Safety, Tolerability and Pharmacokinetics of AZD2516 After Multiple Dosing in Healthy Volunteers". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT01148095. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*